Clinical Trial Update: Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety and efficacy of iodofiltic acid I-123 for treating acute coronary syndrome; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Iodofiltic Acid I-123 (iodofiltic acid)

Snippet

Sponsor: Molecular Insight Pharmaceuticals, Inc. | Conditions: Acute Coronary Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2016-01-25